O'Shaughnessy Asset Management, LLC Mirati Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $8,976 - $12,939	-68 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$132.13 - $177.45 $270,470 - $363,240	-2,047 Reduced 96.78%	68 $12,000
Q2 2021 Aug 09, 2021	BUY	$144.0 - $179.73 $576 - $718	4 Added 0.19%	2,115 $341,000
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $97,735 - $136,290	-615 Reduced 22.56%	2,111 $361,000
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $441,748 - $654,976	2,726 New	2,726 $599,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.